406
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Evaluation of a new topical skin protectant (RD1433) for the prevention and treatment of incontinence-associated dermatitis

, , , , , , , , & show all
Pages 211-219 | Received 26 Sep 2016, Accepted 02 Nov 2016, Published online: 23 Nov 2016

References

  • Gray M, Bliss DZ, Doughty DB, et al. Incontinence-associated dermatitis: a consensus. J Wound Ostomy Continence Nurs 2007;34:45–54
  • Voegeli D. Moisture-associated skin damage: an overview for community nurses. Br J Community Nurs 2013;18:6, 8, 10–12
  • Langemo D, Hanson D, Hunter S, et al. Incontinence and incontinence-associated dermatitis. Adv Skin Wound Care 2011;24:126–140
  • Doughty D, Junkin J, Kurz P, et al. Incontinence-associated dermatitis: consensus statements, evidence-based guidelines for prevention and treatment, and current challenges. J Wound Ostomy Continence Nurs 2012;39:303–315
  • Sugama J, Sanada H, Shigeta Y, et al. Efficacy of an improved absorbent pad on incontinence-associated dermatitis in older women: cluster randomized controlled trial. BMC Geriatr 2012;12:22
  • Bardsley A. Prevention and management of incontinence-associated dermatitis. Nurs Stand 2013;27:41–46
  • Bliss DZ, Savik K, Harms S, et al. Prevalence and correlates of perineal dermatitis in nursing home residents. Nurs Res 2006;55:243–251
  • Liu DK, Wannemacher RW, Snider TH, Hayes TL. Efficacy of the topical skin protectant in advanced development. J Appl Toxicol 1999;19:S40–S45
  • Robinson MK. Intra-individual variations in acute and cumulative skin irritation responses. Contact Dermatitis 2001;45:75–83
  • Borchert K, Bliss DZ, Savik K, Radosevich DM. The incontinence-associated dermatitis and its severity instrument: development and validation. J Wound Ostomy Continence Nurs 2010;37:527–535
  • Bianchi J. Causes and strategies for moisture lesions. Nurs Times 2012;108:20–22
  • Larner J, Matar H, Goldman VS, Chilcott RP. Development of a cumulative irritation model for incontinence-associated dermatitis. Arch Dermatol Res 2015;307:39–48
  • Chilcott RP, Larner J, Matar H, et al. Optimisation of a dosing regime for a topical skin protectant (barrier cream). Cutan Ocul Toxicol 2015;34:327–334
  • Chilcott RP, Farrar R. Biophysical measurements of human forearm skin in vivo: effects of site, gender, chirality and time. Skin Res Technol 2000;6:64–69
  • Mayrovitz HN, Sims N. Biophysical effects of water and synthetic urine on skin. Adv Skin Wound Care 2001;14:302–308
  • Zhai H, Willard P, Maibach HI. Evaluating skin-protective materials against contact irritants and allergens. An in vivo screening human model. Contact Dermatitis 1998;38:155–158
  • Zhai H, Willard P, Maibach HI. Putative skin-protective formulations in preventing and/or inhibiting experimentally-produced irritant and allergic contact dermatitis. Contact Dermatitis 1999;41:190–192
  • Zhai H, Brachman F, Pelosi A, et al. A bioengineering study on the efficacy of a skin protectant lotion in preventing SLS-induced dermatitis. Skin Res Technol 2000;6:77–80
  • Serup J, Agner T. Colorimetric quantification of erythema-a comparison of two colorimeters (Lange Micro Color and Minolta Chroma Meter CR-200) with a clinical scoring scheme and laser-Doppler flowmetry. Clin Exp Dermatol 1990;15:267–272
  • Chilcott RP, Brown RF, Rice P. Non-invasive quantification of skin injury resulting from exposure to sulphur mustard and Lewisite vapours. Burns 2000;26:245–250
  • Basketter D, Reynolds F, Rowson M, et al. Visual assessment of human skin irritation: a sensitive and reproducible tool. Contact Dermatitis 1997;37:218–220
  • Farage MA, Maibach HI, Andersen KE, et al. Historical perspective on the use of visual grading scales in evaluating skin irritation and sensitization. Contact Dermatitis 2011;65:65–75
  • Laffin N, Smyth W, Heyer E, et al. Effectiveness and acceptability of a moisturizing cream and a barrier cream during radiation therapy for breast cancer in the tropics: a randomized controlled trial. Cancer Nurs 2015;38:205–214
  • Peltonen JM, Pylkkänen L, Jansén CT, et al. Three randomised phase I/IIa trials of 5% cis-urocanic acid emulsion cream in healthy adult subjects and in patients with atopic dermatitis. Acta Derm Venereol 2014;94:415–420

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.